These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 31173237)

  • 21. MicroRNA‑126 inhibits proliferation and metastasis by targeting pik3r2 in prostate cancer.
    Song L; Xie X; Yu S; Peng F; Peng L
    Mol Med Rep; 2016 Feb; 13(2):1204-10. PubMed ID: 26677064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR‑19a‑3p targets PMEPA1 and induces prostate cancer cell proliferation, migration and invasion.
    Feng S; Zhu X; Fan B; Xie D; Li T; Zhang X
    Mol Med Rep; 2016 May; 13(5):4030-8. PubMed ID: 27035427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Downregulation of miR‑19a‑3p promotes invasion, migration and bone metastasis via activating TGF‑β signaling in prostate cancer.
    Wa Q; Li L; Lin H; Peng X; Ren D; Huang Y; He P; Huang S
    Oncol Rep; 2018 Jan; 39(1):81-90. PubMed ID: 29138858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-107 inhibits proliferation of prostate cancer cells by targeting cyclin E1.
    Zhang X; Jin K; Luo JD; Liu B; Xie LP
    Neoplasma; 2019 Sep; 66(5):704-716. PubMed ID: 31129966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-631/ZAP70: A novel axis in the migration and invasion of prostate cancer cells.
    Fu D; Liu B; Zang LE; Jiang H
    Biochem Biophys Res Commun; 2016 Jan; 469(3):345-51. PubMed ID: 26620225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-382 inhibits prostate cancer cell proliferation and metastasis through targeting COUP-TFII.
    Zhang W; Liu J; Qiu J; Fu X; Tang Q; Yang F; Zhao Z; Wang H
    Oncol Rep; 2016 Dec; 36(6):3707-3715. PubMed ID: 27748848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo.
    Kiener M; Chen L; Krebs M; Grosjean J; Klima I; Kalogirou C; Riedmiller H; Kneitz B; Thalmann GN; Snaar-Jagalska E; Spahn M; Kruithof-de Julio M; Zoni E
    BMC Cancer; 2019 Jun; 19(1):627. PubMed ID: 31238903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downregulation of ARID4A and ARID4B promote tumor progression and directly regulated by microRNA-30d in patient with prostate cancer.
    Liang YK; Han ZD; Lu JM; Liu ZZ; Zhuo YJ; Zhu XJ; Chen JX; Ye JH; Liang YX; He HC; Zhong WD
    J Cell Biochem; 2018 Sep; 119(9):7245-7255. PubMed ID: 29797600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Downregulation of miR‑505‑3p predicts poor bone metastasis‑free survival in prostate cancer.
    Tang Y; Wu B; Huang S; Peng X; Li X; Huang X; Zhou W; Xie P; He P
    Oncol Rep; 2019 Jan; 41(1):57-66. PubMed ID: 30365141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circular RNA_LARP4 inhibits cell proliferation and invasion of gastric cancer by sponging miR-424-5p and regulating LATS1 expression.
    Zhang J; Liu H; Hou L; Wang G; Zhang R; Huang Y; Chen X; Zhu J
    Mol Cancer; 2017 Sep; 16(1):151. PubMed ID: 28893265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR‑30c suppresses prostate cancer survival by targeting the ASF/SF2 splicing factor oncoprotein.
    Huang YQ; Ling XH; Yuan RQ; Chen ZY; Yang SB; Huang HX; Zhong WD; Qiu SP
    Mol Med Rep; 2017 Sep; 16(3):2431-2438. PubMed ID: 28677791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-539 inhibits prostate cancer progression by directly targeting SPAG5.
    Zhang H; Li S; Yang X; Qiao B; Zhang Z; Xu Y
    J Exp Clin Cancer Res; 2016 Apr; 35():60. PubMed ID: 27037000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-195 Inhibits EMT by Targeting FGF2 in Prostate Cancer Cells.
    Liu C; Guan H; Wang Y; Chen M; Xu B; Zhang L; Lu K; Tao T; Zhang X; Huang Y
    PLoS One; 2015; 10(12):e0144073. PubMed ID: 26650737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MAZ promotes prostate cancer bone metastasis through transcriptionally activating the KRas-dependent RalGEFs pathway.
    Yang Q; Lang C; Wu Z; Dai Y; He S; Guo W; Huang S; Du H; Ren D; Peng X
    J Exp Clin Cancer Res; 2019 Sep; 38(1):391. PubMed ID: 31488180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-383 located in frequently deleted chromosomal locus 8p22 regulates CD44 in prostate cancer.
    Bucay N; Sekhon K; Yang T; Majid S; Shahryari V; Hsieh C; Mitsui Y; Deng G; Tabatabai ZL; Yamamura S; Calin GA; Dahiya R; Tanaka Y; Saini S
    Oncogene; 2017 May; 36(19):2667-2679. PubMed ID: 27893706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulation of miR-191 promotes cell growth and invasion via targeting TIMP3 in prostate cancer.
    Wang X; Shi Z; Liu X; Su Y; Li W; Dong H; Zhao L; Li M; Wang Y; Jin X; Huo Z
    J BUON; 2018; 23(2):444-452. PubMed ID: 29745091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-212 Targets Mitogen-Activated Protein Kinase 1 to Inhibit Proliferation and Invasion of Prostate Cancer Cells.
    Hu B; Jin X; Wang J
    Oncol Res; 2018 Aug; 26(7):1093-1102. PubMed ID: 29321092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CUL4B regulates cancer stem-like traits of prostate cancer cells by targeting BMI1 via miR200b/c.
    Jiao M; Qi M; Zhang F; Hu J; Feng T; Zhao M; Li X; Liu H; Teng W; Zhang J; Liu Z; Zhang L; Wu Z; Han B
    Prostate; 2019 Aug; 79(11):1294-1303. PubMed ID: 31111526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of miR-449a-caused PrLZ overexpression promotes prostate cancer metastasis.
    Chen W; Liu Y; Chen H; Ning H; Ding K
    Int J Oncol; 2017 Aug; 51(2):435-444. PubMed ID: 28627667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CIP2A mediates prostate cancer progression via the c-Myc signaling pathway.
    Guo Z; Liu D; Su Z
    Tumour Biol; 2015 Jun; 36(6):4777-83. PubMed ID: 25636449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.